| scholarly article | Q13442814 |
| P356 | DOI | 10.4049/JIMMUNOL.170.9.4532 |
| P953 | full work available at URL | https://journals.aai.org/jimmunol/article-pdf/170/9/4532/1165178/4532.pdf |
| P698 | PubMed publication ID | 12707330 |
| P5875 | ResearchGate publication ID | 10794726 |
| P2093 | author name string | Wen Yang | |
| Howard M. Grey | |||
| P2860 | cites work | Evidence for a differential avidity model of T cell selection in the thymus | Q45155438 |
| Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor | Q45986774 | ||
| A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists | Q46121537 | ||
| Initiation of signal transduction through the T cell receptor requires the multivalent engagement of peptide/MHC ligands [corrected] | Q46842083 | ||
| An unusual mechanism for ligand antagonism | Q47793287 | ||
| Correlations between T-cell specificity and the structure of the antigen receptor | Q48365072 | ||
| Identification of conserved T cell receptor CDR3 residues contacting known exposed peptide side chains from a major histocompatibility complex class I-bound determinant | Q57082205 | ||
| Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells | Q59078526 | ||
| An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis | Q63535314 | ||
| Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand | Q67903498 | ||
| Cross-antagonism of a T cell clone expressing two distinct T cell receptors | Q73065666 | ||
| Inhibition of TCR triggering by a spectrum of altered peptide ligands suggests the mechanism for TCR antagonism | Q77530678 | ||
| Three-dimensional segregation of supramolecular activation clusters in T cells | Q28282528 | ||
| T cell receptor antagonist peptides induce positive selection | Q29618820 | ||
| Antigen presentation by Ia+ B cell hybridomas to H-2-restricted T cell hybridomas | Q30450024 | ||
| Selection of the T cell repertoire. | Q33652536 | ||
| Negative selection of CD4+ CD8+ thymocytes by T-cell receptor peptide antagonists | Q35213326 | ||
| Effect of T-cell receptor antagonism on interaction between T cells and antigen-presenting cells and on T-cell signaling events | Q36191499 | ||
| Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells | Q36361774 | ||
| Dimerization of soluble major histocompatibility complex-peptide complexes is sufficient for activation of T cell hybridoma and induction of unresponsiveness | Q36365206 | ||
| The stimulation of low-affinity, nontolerized clones by heteroclitic antigen analogues causes the breaking of tolerance established to an immunodominant T cell epitope | Q36375353 | ||
| Potent T cell activation with dimeric peptide-major histocompatibility complex class II ligand: the role of CD4 coreceptor | Q36401714 | ||
| Ligands for the T-cell receptor: hard times for avidity models | Q40543526 | ||
| Antigen analogs/MHC complexes as specific T cell receptor antagonists | Q40661137 | ||
| The relationship of MHC-peptide binding and T cell activation probed using chemically defined MHC class II oligomers | Q40831490 | ||
| Peptide antagonism and T cell receptor interactions with peptide-MHC complexes | Q40996486 | ||
| T-cell-receptor affinity and thymocyte positive selection | Q41192128 | ||
| Vaccination and protection from a lethal viral infection: identification, incorporation, and use of a cytotoxic T lymphocyte glycoprotein epitope | Q41720879 | ||
| Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo | Q41761641 | ||
| T cell receptor (TCR) antagonism without a negative signal: evidence from T cell hybridomas expressing two independent TCRs | Q41826109 | ||
| Antigen-specific signaling by a soluble, dimeric peptide/major histocompatibility complex class II/Fc chimera leading to T helper cell type 2 differentiation | Q41875914 | ||
| Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen | Q43554100 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immunology | Q101929 |
| P304 | page(s) | 4532-4538 | |
| P577 | publication date | 2003-05-01 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Study of the mechanism of TCR antagonism using dual-TCR-expressing T cells | |
| Study of the Mechanism of TCR Antagonism Using Dual-TCR-Expressing T Cells | |||
| P478 | volume | 170 |
| Q34486338 | A CD4+ T cell antagonist epitope down-regulates activating signaling proteins, up-regulates inhibitory signaling proteins and abrogates HIV-specific T cell function |
| Q39611811 | A unique unresponsive CD4+ T cell phenotype post TCR antagonism |
| Q36923916 | Antagonism of HIV-specific CD4+ T cells by C-terminal truncation of a minimum epitope |
| Q35794602 | Defining the parameters necessary for T-cell recognition of ligands that vary in potency. |
| Q38958324 | On Peptides and Altered Peptide Ligands: From Origin, Mode of Action and Design to Clinical Application (Immunotherapy). |
| Q36237834 | Peripheral CD8+ T cell tolerance to self-proteins is regulated proximally at the T cell receptor. |
| Q37023214 | Recombinase-activating gene 1-associated expression of the myelin basic protein 1-11-specific transgenic T-cell receptor in H-2b mice |
| Q36322171 | T cell receptor antagonism interferes with MHC clustering and integrin patterning during immunological synapse formation |
| Q24626152 | T cell recognition of weak ligands: roles of signaling, receptor number, and affinity |
| Q41774778 | T-cell activation: A queuing theory analysis at low agonist density |
| Q30492783 | T-cell antagonism by short half-life pMHC ligands can be mediated by an efficient trapping of T-cell polarization toward the APC |
| Q38477340 | Taming the TCR: antigen-specific immunotherapeutic agents for autoimmune diseases |
Search more.